![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
Alexandria Real Estate Equities Inc
385 E Colorado Blvd
Suite 299
Pasadena, CA 91101
United States
Phone
Email
Website
Recent investment activity
KANDO id: 30642
Corporate information
Official name
Alexandria Real Estate Equities Inc
Registration country
Official identities
US CIK 0001035443
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 17 of 17| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Cerulean Pharma Inc | Series B | ||||
|
|
Genocea Biosciences Inc | N/A | ||||
|
|
Magen BioSciences Inc | N/A | ||||
|
|
MAP Pharmaceuticals Inc | Proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs. | N/A | |||
|
|
Metabolon Inc | Provider of biomarker discovery and analysis | Series C | |||
|
|
MiddleBrook Pharmaceuticals Inc | A pharmaceutical company engages in the development and commercialization of anti-infective drug products. | N/A | |||
|
|
Theraclone Sciences Inc | Series B | ||||
|
|
Theraclone Sciences Inc | N/A | ||||
|
|
VLST Corp | N/A | ||||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Series A Follow-on investment | |||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Seed Initial investment | |||
|
|
BrainCells Inc | A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. | Series B | |||
|
Cambrios Technologies Corp (Cambrios Advanced Materials) | Developer of proprietary nanostructured electronic materials for the display industry | Series D Initial investment | |||
|
|
Concert Pharmaceuticals Inc | A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. | N/A | |||
|
|
MacroGenics Inc | Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. | N/A | |||
|
Nanosys Inc | Nanotechnology-enabled systems | N/A | |||
|
|
Sirtris Pharmaceuticals Inc | Series C |